Jonas Hansson
Biotech entrepreneur
Greater Stockholm Metropolitan Area
Overview
Work Experience
Senior Advisor
2022 - Current
Pretzel Therapeutics mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction through mitochondrial biology.
Raised $72,500,000.00 from University of Cambridge Enterprise, Karolinska, Google Ventures, Mubadala Capital Ventures, Angelini Ventures, Invus, EIR Ventures, HealthCap, ARCH Venture Partners and GU Ventures.
Co-founder & CEO
2022
Purpose Pharma is a patient-centric European based pharmaceutical company focusing on the development and commercialization of novel rare disease and specialty care products in areas of high unmet medical need.
Executive Chairman
2021
Board Member
2021
Partner
2019 - 2022
Venture Partner
2012 - 2019
Medical Associate
2008 - 2012
Board Member
2020 - 2021
Board Member
2020 - 2021
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.
Raised $161,600,000.00 from Abingworth, Rock Springs Capital, Armistice Capital, 5AM Ventures, Novo Holdings, RiverVest and HealthCap.
Senior Advisor
2018 - 2019
Alexion Pharmaceuticals is a biopharmaceutical company that engages in the development and commercialization of mid-to-late-stage therapies.
Raised $5,800,000.00.
Co-founder & CEO
2012 - 2018
Co-founding CEO of Wilson Therapeutics. Raised approx USD 100 million in private and public financings. Acquired by Alexion for USD 855 million.
Nordic Brand Leader
2006 - 2008